{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:15:28Z","timestamp":1781050528910,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.cpcardiol.2023.101811","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T06:34:15Z","timestamp":1684478055000},"page":"101811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and Prognostic Implications of Amyloidosis in Valvular Heart Disease"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2885-2999","authenticated-orcid":false,"given":"Bilal","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchit","family":"Duhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luay","family":"Al-Alawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohail","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhair","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Waqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2023.101811_bib0001","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0002","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.carrev.2022.07.011","article-title":"Aortic stenosis and cardiac amyloidosis: PARTNERs in crime?","volume":"43","author":"Argiro","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0003","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0004","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcmg.2015.04.012","article-title":"Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis","volume":"9","author":"Longhi","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0005","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jcin.2012.03.012","article-title":"Pathology of transcatheter valve therapy","volume":"5","author":"Nietlispach","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0006","unstructured":"Overview of the National (Nationwide) Inpatient Sample (NIS). 2023."},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0007","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0008","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0009","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ejhf.1974","article-title":"Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis","volume":"23","author":"Rosenblum","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0010","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.3390\/jcm10184234","article-title":"Aortic valve stenosis and cardiac amyloidosis: a misleading association","volume":"10","author":"Bonelli","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0011","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro","year":"2018","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0012","unstructured":"Global Prevalence of ATTR-CM in Participants With HFpEF. 2020."},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0013","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0014","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jchf.2019.04.010","article-title":"Screening for transthyretin amyloid cardiomyopathy in everyday practice","volume":"7","author":"Witteles","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0015","first-page":"32","article-title":"Valvular heart disease epidemiology","volume":"10","author":"Aluru","year":"2022","journal-title":"Med Sci (Basel)"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0016","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.mayocp.2020.08.039","article-title":"Mortality due to mitral regurgitation among adults in the United States: 1999-2018","volume":"95","author":"Parcha","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0017","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jcmg.2015.10.023","article-title":"Recognizing transthyretin cardiac amyloidosis in patients with aortic stenosis: impact on prognosis","volume":"9","author":"Sperry","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0018","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","article-title":"Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis","volume":"2","author":"Dorbala","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0019","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jacep.2020.04.019","article-title":"Atrial fibrillation in transthyretin cardiac amyloidosis: predictors, prevalence, and efficacy of rhythm control strategies","volume":"6","author":"Donnellan","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0020","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.cardfail.2013.06.162","article-title":"Clinical predictors of mortality and outcomes in patients with transthyretin cardiac amyloidosis","volume":"19","author":"Tsay","year":"2013","journal-title":"J Card Fail"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0021","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/bjh.15955","article-title":"Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers","volume":"186","author":"Rezk","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0022","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-022-10319-6","article-title":"Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis","volume":"16","author":"Yong","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0023","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ehf2.13701","article-title":"Thromboembolism and bleeding in systemic amyloidosis: a review","volume":"9","author":"Nicol","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0024","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.clml.2018.03.005","article-title":"Serum free light chain difference and \u03b2(2) microglobulin levels are risk factors for thromboembolic events in patients with AL amyloidosis","volume":"18","author":"Park","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0025","article-title":"Outcomes of transcatheter aortic valve replacement in patients with coexisiting amyloidosis","volume":"2","author":"Elzeneini","year":"2023","journal-title":"JACC: Advances"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0026","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jcmg.2020.07.011","article-title":"Prognostic significance of cardiac amyloidosis in patients with aortic stenosis: a systematic review and meta-analysis","volume":"14","author":"Ricci","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2023.101811_bib0027","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/eurheartj\/ehaa170","article-title":"Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation","volume":"41","author":"Scully","year":"2020","journal-title":"Eur Heart J"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623002281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280623002281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T21:21:44Z","timestamp":1741814504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280623002281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0146280623002281"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101811","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and Prognostic Implications of Amyloidosis in Valvular Heart Disease","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101811"}}